Related by context. Frequent words. (Click for all words.) 74 Juergen Engel Ph.D. 74 Thomas B. Okarma 74 David Aviezer 74 Dino Dina 73 Arthur S. Przybyl 73 Edward Lanphier Sangamo 73 Francois Nader 72 Mark A. Sirgo 72 Dr. Randall Yatscoff 71 Michael H. Tardugno 71 Stephen M. Simes 71 Clay B. Siegall 70 David H. Fater 70 J. Donald deBethizy 70 Steve Worland Ph.D. 69 Steven A. Kriegsman 69 George A. Scangos 69 Ron Najafi 68 Jeffrey H. Buchalter 68 Patrick J. Balthrop 68 Onno van de Stolpe 68 Brian JG Pereira 68 MultiCell Technologies 67 Dr. Rahul Singhvi 67 Eamonn Hobbs 67 Shlomo Yanai Teva 67 Æterna Zentaris 67 AVEO Pharmaceuticals 67 Inc. Nasdaq VRUS 66 Jack Lief 66 Sachiko Kuno Ph.D. 66 Sol J. Barer 66 Matthew Emmens 66 Martin Madaus 66 Inc. Nasdaq IMGN 66 Simon Sturge 65 NASDAQ OPXA 65 John Maraganore Ph.D. 65 Gilles Gagnon 65 Genitope Corporation 65 Metabasis Therapeutics Inc. 65 Marijn E. Dekkers 65 Opexa 64 ImmunoCellular Therapeutics 64 Neogenix 64 ARQL 64 Inc. Nasdaq SGEN 64 Chemokine Therapeutics 64 Relypsa 64 www.vivus.com 64 Avila Therapeutics 64 Cyclacel Pharmaceuticals 64 Thomas R. Watjen 64 Jack Lief Arena 64 PhytoMedical Technologies Inc. 64 Larry W. Reaugh 64 Kevin Hrusovsky President 64 Abbas Mohaddes 64 Tom Reslewic 64 Sunesis Pharmaceuticals 64 Dr. Magid Abraham 63 Richard L. Bready 63 Emisphere Technologies 63 Kevin Buchi 63 Annual BIO 63 Jean Jacques Bienaime 63 Scott Huennekens 63 Covalon Technologies Ltd. 63 Genaera Corporation 63 Diatos 63 Paul Cofoni CACI 63 HepaLife Technologies Inc. 63 Inc. Nasdaq INFI 63 CombinatoRx Incorporated NASDAQ CRXX 63 Thomas Okarma 63 Inc. NASDAQ EXEL 63 VIA Pharmaceuticals 63 Ardea Biosciences 63 Lisa N. Drakeman 63 www.epixpharma.com 63 Inc. Nasdaq EXEL 63 George Scangos 63 Rick Spurr 63 Celsion Corporation 63 Harbor BioSciences 62 ImmuneRegen BioSciences Inc. 62 Ben Lipps 62 Synergy Pharmaceuticals 62 NASDAQ ARIA 62 PsychoGenics 62 Cempra 62 Inc. NASDAQ DEPO 62 Sunesis Pharmaceuticals Inc. 62 Daniel Von Hoff 62 Kiadis Pharma 62 www.delcath.com 62 CardioVascular BioTherapeutics Inc. 62 Cerus Corporation 62 MedNet Solutions 62 Urigen Pharmaceuticals Inc. 62 A. Pontius